Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Tumor necrosis factor-associated periodic syndrome in adults.

Menon SG, Efthimiou P.

Rheumatol Int. 2018 Jan;38(1):3-11. doi: 10.1007/s00296-017-3820-4. Epub 2017 Sep 23. Review.

PMID:
28942479
2.

IgG4-related disease: a complex under-diagnosed clinical entity.

Yadlapati S, Verheyen E, Efthimiou P.

Rheumatol Int. 2018 Feb;38(2):169-177. doi: 10.1007/s00296-017-3765-7. Epub 2017 Jul 5. Review.

PMID:
28681251
3.

Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis.

Bello AE, Perkins EL, Jay R, Efthimiou P.

Open Access Rheumatol. 2017 Mar 31;9:67-79. doi: 10.2147/OARRR.S131668. eCollection 2017. Review.

4.

Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk?

Yadlapati S, Efthimiou P.

Biomed Res Int. 2016;2016:8631061. doi: 10.1155/2016/8631061. Epub 2016 Jun 27. Review.

5.

Inadequate response or intolerability to oral methotrexate: Is it optimal to switch to subcutaneous methotrexate prior to considering therapy with biologics?

Yadlapati S, Efthimiou P.

Rheumatol Int. 2016 May;36(5):627-33. doi: 10.1007/s00296-016-3447-x. Epub 2016 Mar 2. Review.

PMID:
26936262
6.

Screening Optimization of Latent Tuberculosis Infection in Rheumatoid Arthritis Patients.

Mehta B, Zapantis E, Petryna O, Efthimiou P.

Arthritis. 2015;2015:569620. doi: 10.1155/2015/569620. Epub 2015 Jul 29.

7.

Impact of IL-1 inhibition on fatigue associated with autoinflammatory syndromes.

Yadlapati S, Efthimiou P.

Mod Rheumatol. 2016;26(1):3-8. doi: 10.3109/14397595.2015.1069459. Epub 2015 Aug 3. Review.

PMID:
26140469
8.

Use of B lymphocyte stimulator inhibitor belimumab may be associated with a decrease in the serum concentration of epidermal growth factor in patients with primary Sjögren's syndrome.

Kadavath S, Bobic S, Efthimiou P.

Clin Rheumatol. 2015 Sep;34(9):1651-2. doi: 10.1007/s10067-015-2872-7. Epub 2015 Feb 5. Review.

PMID:
25652332
9.

Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options.

Kadavath S, Efthimiou P.

Ann Med. 2015 Feb;47(1):6-14. doi: 10.3109/07853890.2014.971052. Epub 2015 Jan 22. Review.

PMID:
25613167
10.

A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6.

Kadavath S, Zapantis E, Zolty R, Efthimiou P.

Int J Rheum Dis. 2014 Mar;17(3):336-40. doi: 10.1111/1756-185X.12324. Epub 2014 Feb 28. Review.

PMID:
24581387
11.

Life-threatening complications of adult-onset Still's disease.

Efthimiou P, Kadavath S, Mehta B.

Clin Rheumatol. 2014 Mar;33(3):305-14. doi: 10.1007/s10067-014-2487-4. Epub 2014 Jan 17. Review.

PMID:
24435354
12.

Can traumatic injury trigger psoriatic arthritis? A review of the literature.

Hsieh J, Kadavath S, Efthimiou P.

Clin Rheumatol. 2014 May;33(5):601-8. doi: 10.1007/s10067-013-2436-7. Epub 2013 Nov 19. Review.

PMID:
24249146
13.

Adult Onset Still's Disease and Autoinflammation.

Efthimiou P, Moorthy LN, Mavragani CP, Skokos D, Fautrel B.

Int J Inflam. 2012;2012:964751. doi: 10.1155/2012/964751. Epub 2012 Aug 29. No abstract available.

14.

IL-1 Trap rilonacept in refractory adult onset Still's disease.

Petryna O, Cush JJ, Efthimiou P.

Ann Rheum Dis. 2012 Dec;71(12):2056-7. doi: 10.1136/annrheumdis-2012-201409. Epub 2012 Jun 7. No abstract available.

PMID:
22679302
15.

Ferritin in adult-onset still's disease: just a useful innocent bystander?

Mehta B, Efthimiou P.

Int J Inflam. 2012;2012:298405. doi: 10.1155/2012/298405. Epub 2012 Mar 25. Erratum in: Int J Inflam. 2012;2012:254858.

16.

The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease.

Kontzias A, Efthimiou P.

Semin Arthritis Rheum. 2012 Oct;42(2):201-5. doi: 10.1016/j.semarthrit.2012.03.004. Epub 2012 Apr 17.

PMID:
22512815
17.

Radiographic improvement in sarcoid arthropathy after infliximab treatment.

Mehta B, Efthimiou P.

J Rheumatol. 2012 Mar;39(3):664-5. doi: 10.3899/jrheum.111002. No abstract available.

PMID:
22383361
18.

Lupus pernio: sarcoid-specific cutaneous manifestation associated with chronic sarcoid arthropathy.

Efthimiou P, Kukar M.

J Clin Rheumatol. 2011 Sep;17(6):343. doi: 10.1097/RHU.0b013e31822e0df0. No abstract available.

PMID:
21885927
19.

PCP chemoprophylaxis is essential for lymphopenic dermatomyositis patients treated with immunomodulators.

Efthimiou P, Pokharna H, Kukar M, Hennessey K.

Muscle Nerve. 2011 Jun;43(6):918-9. doi: 10.1002/mus.21997. Epub 2011 Apr 12. No abstract available.

PMID:
21488055
20.

Rituximab and lupus interstitial lung disease: friend or foe?

Efthimiou P, Kukar M, Hersh A.

Int J Rheum Dis. 2011 Feb;14(1):e3-4. doi: 10.1111/j.1756-185X.2010.01592.x. Epub 2011 Jan 24. No abstract available.

PMID:
21303472
21.

Headache from cavernous sinus thrombosis in Adamantiades-Behçet disease.

Efthimiou P, Petryna O.

J Clin Rheumatol. 2010 Dec;16(8):409. doi: 10.1097/RHU.0b013e31820059ca. No abstract available.

PMID:
21119387
22.

Clinical Image: posterior reversible encephalopathy syndrome as a severe manifestation of neuropsychiatric systemic lupus erythematosus.

Efthimiou P, Kukar M, Krishnan P.

Arthritis Rheum. 2010 Jun;62(6):1692. doi: 10.1002/art.27471. No abstract available.

23.

Images in rheumatology. Severe adult-onset calcinosis in a patient with a history of juvenile dermatomyositis.

Efthimiou P, Kukar M, Kagen LJ.

J Rheumatol. 2010 Jan;37(1):194. doi: 10.3899/jrheum.090628. No abstract available.

PMID:
20040639
24.

An unusual cause of lower back pain.

Petryna O, Efthimiou P.

J Rheumatol. 2009 Nov;36(11):2556. doi: 10.3899/jrheum.090498. No abstract available.

PMID:
19893061
25.

Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used modalities.

Efthimiou P, Kukar M.

Rheumatol Int. 2010 Mar;30(5):571-86. doi: 10.1007/s00296-009-1206-y. Epub 2009 Oct 30. Review.

PMID:
19876631
27.

Complementary and alternative medicine in rheumatoid arthritis: no longer the last resort!

Efthimiou P, Kukar M, Mackenzie CR.

HSS J. 2010 Feb;6(1):108-11. doi: 10.1007/s11420-009-9133-8. Epub 2009 Sep 26.

28.

Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers.

Efthimiou P, Blanco M.

Mod Rheumatol. 2009;19(5):457-68. doi: 10.1007/s10165-009-0198-5. Epub 2009 Jul 18. Review.

PMID:
19618249
29.

Isolated severe vasculitic neuropathy revealing sarcoidosis.

Souayah N, Chodos A, Krivitskaya N, Efthimiou P, Lambert WC, Sharer LR.

Lancet Neurol. 2008 Aug;7(8):756-60. doi: 10.1016/S1474-4422(08)70166-2. No abstract available.

PMID:
18635023
30.

Autoinflammatory syndromes and infections: pathogenetic and clinical implications.

Efthimiou P, Flavell RA, Furlan A, Gasbarrini G, Gava A, Koné-Paut I, Manna R, Punzi L, Sutterwala FS, Touitou I, Doria A.

Clin Exp Rheumatol. 2008 Jan-Feb;26(1 Suppl 48):S53-61. Review.

PMID:
18570755
31.

Classic presentation of a rare disease: melorheostosis.

Efthimiou P, Nasis O, Russell LA.

J Rheumatol. 2008 Jun;35(6):1169. No abstract available.

PMID:
18528951
32.

Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances.

Kontzias A, Efthimiou P.

Drugs. 2008;68(3):319-37. Review. Erratum in: Drugs. 2011 Oct 1;71(14):1820.

PMID:
18257609
33.

Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature.

Efthimiou P, Blanco M.

Semin Arthritis Rheum. 2008 Dec;38(3):188-94. doi: 10.1016/j.semarthrit.2007.10.015. Epub 2008 Jan 25.

PMID:
18221985
34.

Aortic aneurysm in Takayasu's arteritis.

Efthimiou P, Nasis O, Lehman TJ.

J Rheumatol. 2007 Nov;34(11):2312. No abstract available.

PMID:
17985414
35.

Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?

Efthimiou P, Kontzias A, Ward CM, Ogden NS.

Nat Clin Pract Rheumatol. 2007 Jun;3(6):328-35. Review.

PMID:
17538564
36.

QuantiFERON TB Gold Test: the new standard for screening of latent tuberculosis in patients with rheumatoid arthritis?

Efthimiou P, Sood S.

Ann Rheum Dis. 2007 Feb;66(2):276. Epub 2006 Nov 24. No abstract available.

37.

Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implications.

Efthimiou P.

Semin Arthritis Rheum. 2006 Dec;36(3):168-72. Epub 2006 Sep 12. Review.

PMID:
16970978
38.

Pathogenesis and management of adult-onset Still's disease.

Efthimiou P, Georgy S.

Semin Arthritis Rheum. 2006 Dec;36(3):144-52. Epub 2006 Sep 1. Review.

PMID:
16949136
39.

Systemic and localized scleroderma in children: current and future treatment options.

Rosenkranz ME, Agle LM, Efthimiou P, Lehman TJ.

Paediatr Drugs. 2006;8(2):85-97. Review. Erratum in: Paediatr Drugs. 2006;8(4):270. Dosage error in article text.

PMID:
16608370
40.
41.

Management of musculoskeletal complications in endstage renal disease: an update.

Ramaswamy D, Efthimiou P, Gnanasekharan I, Soni A.

Clin Rheumatol. 2006 Jul;25(4):440-2. Epub 2005 Nov 3. Review.

PMID:
16267605
42.

Diagnosis and management of adult onset Still's disease.

Efthimiou P, Paik PK, Bielory L.

Ann Rheum Dis. 2006 May;65(5):564-72. Epub 2005 Oct 11. Review.

43.

Role of biological agents in immune-mediated inflammatory diseases.

Efthimiou P, Markenson JA.

South Med J. 2005 Feb;98(2):192-204. Review.

PMID:
15759950
44.

T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase.

Musch MW, Clarke LL, Mamah D, Gawenis LR, Zhang Z, Ellsworth W, Shalowitz D, Mittal N, Efthimiou P, Alnadjim Z, Hurst SD, Chang EB, Barrett TA.

J Clin Invest. 2002 Dec;110(11):1739-47.

Supplemental Content

Loading ...
Support Center